![]() |
The AI in Business PodcastAuthor: Daniel Faggella
The AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI. Each week, Emerj AI Research CEO Daniel Faggella and team interview top AI executives from Fortune 2000 firms and unicorn startups - uncovering trends, use-cases, and best practices for practical AI adoption. Visit our advertising page to learn more about reaching our executive audience of Fortune 2000 AI adopters: https://emerj.com/advertise Language: en Genres: Business, Management, Technology Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Accelerate and Mitigate Risk in Clinical Development - with Panos Karelis of Intelligencia AI
Monday, 10 March, 2025
Today’s guest is Panos Karelis, Director of Customer Experience and Insights at Intelligencia AI. Intelligencia AI is a life sciences technology company that uses proprietary data, biomedical expertise, and AI-driven algorithms to assess the probability of technical and regulatory success for drug candidates, helping pharmaceutical companies make informed decisions on which drugs to advance or discontinue. Panos joins us on today’s show to explore the key challenges and opportunities in AI adoption for drug development. He discusses the “black box” problem in AI and the importance of transparency and explainability in building trust. Panos also highlights the role of high-quality, harmonized data in generating accurate AI-driven insights and the mindset shift required for organizations to integrate AI-assisted decision-making successfully. Additionally, he explains how AI can optimize clinical trial design, enhance portfolio management, and improve business development and licensing decisions. This episode is sponsored by Intelligencia AI. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.